80.00PLN-1.11%Mkt Cap: 113.35M $P/E: —Today
Bioceltix S.A. engages in the development of veterinary biologics based on mesenchymal stem cells. The company's products include BCX-CM-J, a stem-cell based medicinal drug for the treatment of osteoarthritis in dogs; BC…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap113.35M $
Enterprise Value98.01M $
Revenue (TTM)—
Gross Profit-517.47K $
Net Income (TTM)-3.84M $
Revenue/Share—
Last Price80.00 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees46
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLBCLTX00019
Valuation
P/E (Trailing)—
P/E (Forward)-42.16
PEG—
EV/EBITDA-23.52
EV/Revenue—
P/S—
P/B6.56
EPS (TTM)-3.29
EPS (Forward)—
52W Range
70.0026% of range108.00
52W High108.00 PLN
52W Low70.00 PLN
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-20.69%
ROA-20.04%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.03M $
CapEx (TTM)498.97K $
FCF Margin—
FCF Yield-3.36%
Net Debt-15.34M $
Net Debt/EBITDA3.68
Balance Sheet
Debt/Equity0.00
Current Ratio22.56
Quick Ratio22.49
Book Value/Sh12.22 PLN
Cash/Share10.99 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)133.00 PLN
Upside (mean)+66.3%
Target Range133.00 PLN – 133.00 PLN
# Analysts1
Ownership
Shares Out.5.53M
Float4.44M
Insiders19.77%
Institutions22.56%
Technical
SMA 5088.43 (-9.5%)
SMA 20084.86 (-5.7%)
Beta0.92
S&P 52W Chg18.16%
Avg Vol (30d)10.59K
Avg Vol (10d)7.00K
Technical Indicators
RSI (14)39.1
MACD-2.7038
MACD Signal-2.3311
MACD Hist.-0.3727
BB Upper100.86 PLN
BB Middle85.78 PLN
BB Lower70.71 PLN
BB Width35.14%
ATR (14)2.760 PLN
Vol Ratio (20d)0.15x